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Purpose—African American (AA) adults with chronic kidney disease (CKD) have a faster
progression to end stage renal disease (ESRD) and are less likely to receive a kidney transplant. It
is unclear whether AA children experience renal replacement therapy (RRT) for ESRD sooner
than non-AA children after accounting for socioeconomic status (SES).
Methods—Among children with non-glomerular CKD in the Chronic Kidney Disease in
Children (CKiD) study, we investigated time to RRT (i.e., first dialysis or transplant) after CKD
onset using parametric survival models and accounted for SES differences by inverse probability
weights (IPWs).
Results—Of 110 AA and 493 non-AA children (median age= 10 years), AA children had shorter
time to first RRT: median time was 3.2 years earlier than non-AA children (95%CI: −6.1, −0.3).
When accounting for SES, this difference was diminished and non-significant (−1.6 years; 95%CI:
−4.6, +1.5) and its directionality was consistent with faster GFR decline among AA children
(−6.2% vs. −4.4% per year, p= 0.098). When RRT was deconstructed into dialysis or transplant,
the time to dialysis was 37.5% shorter for AA children and 53.7% longer for transplant. These
inferences were confirmed by the frequency and timing of transplant after initiating dialysis.
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Conclusions—Racial differences in time to RRT were almost fully accounted for by SES and
the remaining difference was congruent with a faster GFR decline among AA children. Access to
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transplant occurred later, yet times to dialysis were shorter among AA children even when
accounting for SES which may be due to a lack of organ availability.
Keywords
pediatric nephrology; chronic kidney disease; health disparities; renal replacement therapy; inverse
probability weights

INTRODUCTION

Author Manuscript

African-Americans (AAs) with chronic kidney disease (CKD) have a higher rate of CKD
progression and incidence of end stage renal disease (ESRD) [1] than non-AAs.
Additionally, AA adults are less likely to have renal transplantation than non-AA adults with
ESRD [2], although recent work suggests these differences are attenuating over time [3].
Racial and socioeconomic status (SES) differences in CKD severity observed in adults [4–6]
are also reported in pediatric populations [7,8].
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Several potential causes for racial differences in CKD progression exist. One recently
identified cause among adults and children is the high risk APOL1 genotype [9–12], which
is prevalent in about 13% of the AA population [10] and is associated with focal segmental
glomerulosclerosis [12] and increased incidence of ESRD. Other research has shown that
low SES, lack of social support, perceptions of poor treatment by medical professionals and
a lack of knowledge of renal disease and treatment contribute to worse outcomes among AA
adults, and a lower likelihood of kidney transplant referral [13–15]. Racial differences in
transplant access have also been observed in pediatric populations and this difference is
largely, but not entirely due to SES [16,17]. In the present analysis, we further investigate the
association of AA race with the initiation of dialysis and kidney transplantation in a large,
epidemiologic cohort of children with CKD who were free of APOL1, a genetic risk factor
for accelerated CKD progression. Since kidney transplantation is the preferred method of
treatment for children with late stage CKD [18,19], we sought to explore and characterize
any racial differences in time to first renal replacement therapy (RRT) and the initiation of
different RRT modalities (dialysis or transplant) to help define targets for improved clinical
management.
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Since AA race is strongly related to glomerular disease due to the APOL1 genotype [12,20],
and glomerular disease is related to different disease trajectories than non-glomerular causes
[21], we restricted to children with a non-glomerular cause of CKD (comprising most of the
pediatric CKD population [22–24]) in the Chronic Kidney Disease in Children (CKiD) study
and considered free of the high risk APOL1 genotype. A primary challenge in characterizing
racial differences is accounting for the confounding effects of SES [25–27]. To address this,
inverse probability of exposure weights [28,29] were used as a marginal structural model
approach to account for SES as a confounder of the relationship between race and
progression to first RRT. Our specific aims were to a) characterize disease progression (time
to RRT and changes in GFR) by race (AA vs. non-AA) using the clinically meaningful time
scale of years since CKD onset; b) use inverse probability weights to account for SES as a
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confounder of the race and CKD progression relationship; and c) compare deconstructed
RRT events (i.e., first occurrence of dialysis and transplant) by race accounting for SES.

MATERIALS AND METHODS
Study participants and design
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The CKiD study is a prospective observational cohort study initiated in 2003 to investigate
the natural history of CKD, with participants recruited at 54 pediatric nephrology centers in
the US and Canada. Children were eligible for enrollment in CKiD based on age (1–16
years) and estimated glomerular filtration rate (eGFR) (30–90 mL/min/1.73m2). The
primary diagnosis of CKD was determined at baseline for each participant and adjudicated
as either non-glomerular or glomerular. Non-glomerular diagnoses included the following
conditions: aplastic/hypoplastic/dysplastic kidneys, cystinosis, medullary cystic disease/
juvenile nephronophthisis, and obstructive uropathy, among others; full descriptions of the
CKD diagnoses have been reported [30,31]. The study protocol was approved by the
Institutional Review Boards of each participating center and informed consent and assent
were obtained from all participants according to local requirements.
African American race and APOL1 genotype
The primary exposure of interest was parental or self-reported African American race based
on selection of “white, black/African American, American Indian/Alaska Native, Asian,
Native Hawaiian/Pacific Islander, or other”. AA participants were characterized by the
presence of any “black/African American” response.
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Of 115 AA children with non-glomerular CKD, 84 had consented to genetic testing and
were genotyped for APOL1 risk alleles. Only 6% (5/84) were identified as having APOL1
high risk alleles and we excluded these children from our analytic sample since APOL1
status potentially confounds the race and ESRD relationship. Since 94% of AA children
with non-glomerular disease and genetic testing were free of high risk APOL1, we assumed
the remaining 31 who were not tested were also free of this risk profile.
Outcomes
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The scale for time to first RRT was years since CKD onset, as determined by congenital
origin of disease or the estimated time origin of pathology based on participant or clinical
report. Time since CKD onset was anchored at 2 years (i.e., entry to analysis began at 2
years after CKD onset), since there were few children enrolled in CKiD at early stages of
their disease. Annual estimated GFR measurements were calculated from serum creatinine,
cystatin c and blood urea nitrogen from equations developed in the CKiD study [32].
Adjustment for socioeconomic status
Inverse probability weighting methods [28,29] were used to account for confounding due to
socioeconomic status. Logistic regression was used to generate propensity scores with AA
race as the outcome and variables related to the construct of socioeconomic status at the time
of study entry. Variables included household income (categorized with cutoff values at $30
000 and $75 000 which were chosen to have approximately a third of the study population in

Ann Epidemiol. Author manuscript; available in PMC 2017 November 01.

Ng et al.

Page 4

Author Manuscript

each category), abnormal birth history (a single variable defined as birthweight less than
2500 grams or less than 36 weeks gestational age or birth weight for gestational age less
than 10th percentile), receiving food assistance in the past year, family receiving any form of
public insurance, maternal education less than college, and not having a private doctor visit
in the past year). Male sex was also included as a covariate in this propensity score model
since there were proportionally more boys in the AA group. The inverse of these propensity
for exposure scores (p for AA participants and 1−p for non-AA participants) were scaled
(stabilized) to the marginal proportion for each group [33]. To check for balance of
propensity scores and confounding covariates, the distributions of propensity scores and
univariate weighted differences were compared. The analysis of the adjusted association of
AA race and outcome reduces to a simpler analysis by weighting each individual to his/her
inverse probability weight.
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Analysis of time to renal replacement therapy and longitudinal changes in GFR
Incorporating left truncation due to children being enrolled at different lengths of time since
2 years past CKD onset, non-parametric estimates of survival functions were derived for
RRT, as a composite event, and then for dialysis and transplant as competing events.
Parametric accelerated failure time models using the Weibull distribution stratified by race
were fit for RRT as the event, allowing each race group to modify both the location (β;
determinant of median time of survival) and scale (σ; determinant of interquartile ratio)
parameters [34]. The pth percentile of a Weibull distribution (WE(β, σ)) is exp(β) ×
[−ln(1−p)]σ. We used the ratio of percentiles (AA to non-AA) as the measure of association
which is constant in the particular case of equal scale parameters. The models (unweighted
and weighted) were evaluated based on the goodness of fit to the non-parametric survival
curves.
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Changes in GFR over time were characterized by a linear mixed effects model (unweighted
and weighted) with random intercepts and slopes. The dependent variable was GFR (in the
log scale) and the independent variables were years from study entry, an indicator for AA
race and the interaction between years and AA.
Dialysis and transplant as competing events and transplantation after dialysis
Mixtures of two Weibull distributions using maximum likelihood methods jointly described
the incidence of dialysis and transplant as competing events [35]. For each competing event,
parameter estimation included β and σ (describing the Weibull distributions) and π
(corresponding to the proportion undergoing dialysis, with 1 − π describing the proportion
undergoing transplant), and these were allowed to vary by race.
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Although considering the first occurrence of dialysis and transplantation is congruent with a
competing risks approach, categorizing first RRT by dialysis or transplant is a limitation
since dialysis is often a preparatory therapy for future transplant. To address this, the
incidence of and timing to transplant after the initiation of dialysis was described by race.
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RESULTS
Of the total 891 children in CKiD, 616 (69%) had an underlying non-glomerular cause of
CKD, of whom 501 were non-AA with the remaining 115 self-reported as AA. Eight nonAA children were excluded because they had an unknown date of CKD onset or had no
follow-up time. Of the 115 AA children, 5 were identified as having the high risk APOL1
genotype and were excluded since they were considered at higher genetic risk for
accelerated CKD progression. A total of 603 (493 non-AA and 110 AA children) comprised
the analytic sample.
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Table 1 presents characteristics at study entry of the participants stratified by race. The AA
children were more likely to be boys (75% vs. 64%), have had an abnormal birth history
(45% vs 29%), have any form of public health insurance (64% vs. 40%), be from a low
income household (61% vs. 27%), have a maternal education less than college (79% vs.
65%), have received food assistance (35% vs. 15%), and were less likely to have seen a
private MD in the previous year (61% and 75%).
Among the 493 non-AA children, 104 (21%) initiated RRT: 47 (10% of 493) received
dialysis first and 57 (12% of 493) received transplant first. Of the 110 AA children, 31
(28%) initiated RRT, of whom 25 (23% of 110) received dialysis and 6 (5% of 110) received
kidney transplant as their initial RRT modality.
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Propensity scores were developed from a logistic regression model using SES variables as
predictors of the outcome of AA race (presented in Table 2). The strongest associations with
AA race were being a boy (OR: 2.33), household income (OR for low income: 2.31; OR for
high income: 0.37), and abnormal birth history (OR: 2.12). While the other variables were
not statistically significantly associated, their inclusion was necessary to obtain balance on
indicators of SES. Propensity scores (p) for each participant were generated from this model
and converted to inverse probability weights (IPWs) and scaled to the marginal proportions
of non-AA and AA children [33] such that the weight for the ith AA participant was equal to
(110/603)/pi; and for the jth non-AA participant was equal to (493/603)/(1−pj). After
applying the IPWs to the dataset, Table 3 describes the univariate differences as a diagnostic
evaluation for balance on key variables. Balance was achieved such that there were no
significant differences for the SES variables (and gender) that were included in the model.
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Figure 1A displays the unadjusted non-parametric estimates of time to RRT with Weibull
models superimposed for both non-AA and AA children. The median time to RRT was 3.2
years earlier for AA children compared to non-AA children (95%CI: −6.1, −0.3). In
contrast, Figure 1B shows the same plot weighted according to the IPWs that account for
SES indicators. There were no differences in time to RRT between AA and non-AA children
until about 16 years after disease onset, at which point more AA children experienced RRT
than non-AA children. Compared to non-AA children, the median time to RRT in the
weighted analysis was only 1.6 years shorter for AA children (95%CI: −4.6, +1.5). A full
description of the models, including levels of statistical significance, are presented in
Supplemental Table 1.
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Table 4 presents the results from the longitudinal model characterizing GFR changes over
time. AA children had a faster rate of GFR decline than non-AA children (−6.2% vs. −4.3%,
p for difference= 0.040), and these rates persisted even when adjusting for SES factors
although the difference was borderline significant (−6.2% vs. −4.4%, p for difference=
0.098).
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Figures 2A and 2B present the joint estimated time to dialysis and transplant as competing
first RRT events, by race, based on unadjusted and adjusted (i.e., weighted) analyses,
respectively. Mixtures of Weibull distributions for each event were estimated in a unified
model [34–36] and are included as dashed lines in the graphs. Only the location parameters
(βs) differed by race. The differences were attenuated but remained substantial when
weighted to adjust for SES. The weighted model indicated that AA children had a 37.5% (=
[exp(2.71 − 3.18) − 1] × 100) shorter time to dialysis as first RRT (95%CI: −60.9%, −0.2%),
and 53.7% (= [exp(3.14 − 2.71) − 1] × 100) longer time to transplant as first RRT(95%CI:
−10.4%, +164.0%). A full description of the models, including levels of statistical
significance, are presented in Supplemental Table 2.
Figure 3 depicts the frequency and timing of transplantation for children who initiated
dialysis, by race. Among the 47 non-AA children whose first RRT was dialysis, 57% (27)
received transplant at a later date (median years after dialysis= 0.41, IQR= 0.22, 1.12). In
contrast, among the 25 AA children who initially received dialysis, 28% (7) received
transplant afterward (median years after dialysis= 1.19, IQR= 0.57, 3.24). These results were
consistent with the analysis deconstructing RRT initiation to dialysis and transplant.

DISCUSSION
Author Manuscript
Author Manuscript

Our study showed that among children with a non-glomerular cause of CKD, socioeconomic
factors largely explained the unadjusted faster progression to first RRT observed in AA
relative to non-AA children. Nonetheless, using a competing risks approach to dissect the
type of RRT and after adjusting for SES factors, AA children were more likely to receive a
kidney transplant as the first RRT at substantially longer times after CKD onset. Using
decline in GFR as another measure of CKD progression, we showed that AA children of
comparable SES to non-AA children did decline faster. This is congruent with a slightly
earlier time to initiate RRT in adjusted analysis (1.6 years earlier) and more importantly,
may in part explain why dialysis was offered as the first therapy for ESRD among AA
children compared to transplant. We speculate that differential GFR trajectories by race may
perhaps be due to unmeasured genetic (e.g., non-APOL1) or metabolic factors, but it is more
likely due to unmeasured SES variables that are strongly related to this particular disease
process [37].
While time to RRT and GFR decline are two metrics of disease progression, there are
important distinctions between the two. Time to RRT reflects a component of biological
disease processes, but is also determined largely by clinical decisions, family preparedness/
consent, and availability of organs. These variables are likely strongly influenced by SES
factors. Decline in GFR is a physiologic measure of disease progression which may be less
associated with the measured SES variables.
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A major challenge in investigating racial health differences is disentangling the effect of SES
factors and race [27]. Using inverse probability of exposure weights worked well to
accomplish this and provided marginal estimates of effect (i.e., the overall effect in the
population had the SES factors been equally distributed by race [38]). Parametric survival
methods and mixture models offered a full characterization of times to first RRT and
specific modalities and fit the data well, a major strength of this analysis [34–36]. This
approach extended beyond hazard ratios (a commonly used metric of risk) and provided a
richer characterization of times to event [36]. In addition, the mixture approach is free of the
assumptions of proportionality of cause-specific and subhazard functions which in the
context of competing risks is perilous [39]. These parametric models allow for calculation of
hazard ratios, and also provide the distributions of times to event and proportions
experiencing each competing event (dialysis or transplantation), which offers a more
complete epidemiologic description of RRT in this population. To our knowledge, this paper
is the first to use the clinically and epidemiologically meaningful time scale of years since
CKD onset to characterize time to treatment for ESRD, rather than study entry. Allowing for
late entries capitalized on the heterogeneity of disease onset and study entry in the cohort.
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There were several limitations to this analysis. First, this analysis assumed that 31 AA
children who were not genotyped for APOL1 were free of the high risk alleles. This
assumption was based on the finding that 79 of 84 children (94%) tested for APOL1 did not
have the high risk genotype. The impact of misclassification was expected to be low
although we cannot discount this as a missing data problem. Secondly, this study did not
include RRT incidence during the first two years after CKD onset since the study had only
few children recruited at those early times. Third, this analysis did not include neighborhood
level SES characteristics which likely also play a role in incidence of ESRD. It should be
noted though that individual SES explained nearly all of the observed racial differences in
time to RRT.
The differences observed in initial therapy modality after adjusting for SES may reflect
sociocultural and institutional differences not captured by SES. Furthermore, transplantation
is intimately linked to organ availability from donors of similar blood types, tissue markers
and genetic characteristics, all factors associated with race. This likely explains earlier
dialysis among AA children in CKiD since previous work has suggested that AA children
are less likely to receive living donor transplants, despite increased deceased donor
transplants for all children, due to their higher priority and change in allocation policy in
2005 [40].
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With numerous adult [6,13,41] and pediatric studies [16,19,40,42] describing racial
differences in CKD progression and RRT, disparities in access to kidney transplantation, not
explained by SES, persisted in the CKiD cohort. This suggests that factors outside of
physician roles may be more effective to reduce these differences, such as public health
interventions to increase donor availability, promote patient and family adherence to therapy,
and encourage completion of the transplant evaluation process for activation on the
transplant waiting list.
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Figure 1.

Author Manuscript

Figure 1A. Unadjusted non-parametric survival step functions of incidence of first renal
replacement therapy (RRT), by race. Figure 1B. Weighted by inverse probability weights
non-parametric survival step functions of incidence of first RRT adjusted for socioeconomic
status (SES) factors listed in Table 2. Dashed lines are based on Weibull distributions for
each group with location (β) and scale (σ) and denoted as WE(β,σ).
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Figure 2.

Author Manuscript

Figure 2A. Unadjusted non-parametric survival step functions of incidence of first
occurrence of dialysis or transplant as competing events, by race. Figure 2B. Weighted by
inverse probability weights non-parametric survival step functions of incidence of first
occurrence of dialysis or transplant as competing events, by race, adjusted for
socioeconomic status (SES). Dashed lines are based on a mixture of Weibull distributions
for each group with location (β) and scale (σ) and denoted as WE(β,σ) with corresponding
estimated proportions experiencing each competing event.

Author Manuscript
Ann Epidemiol. Author manuscript; available in PMC 2017 November 01.

Ng et al.

Page 14

Author Manuscript
Author Manuscript
Figure 3.
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Frequency and timing of kidney transplant after first dialysis, by race. Line segments around
proportions receiving transplant are 95% exact confidence intervals. Percentile boxplots
depict the distributions of times to transplant after first dialysis.
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Table 1

Author Manuscript

Baseline descriptive statistics (Median [IQR] or % (n)) of demographic, socioeconomic and clinical
characteristics by race among children with a non-glomerular cause of CKD. P-values are based on the
Wilcoxon rank sum test for continuous variables and Fisher’s exact test for categorical variables.
Variable

Non-African American
N= 493

African American
N= 110

Age at study entry

10.2 [6.6, 13.7]

9.6 [5.4, 13.2]

0.282

Male

64% (314)

75% (83)

0.020

Hispanic ethnicity

15% (73)

10% (11)

0.224

Congenital CKD

72% (353)

80% (88)

0.075

Birth weight (g)

3175 [2778, 3600]

3005 [2523, 3400]

0.010

Abnormal birth history

29% (137)

45% (45)

0.002

Any private insurance

73% (349)

46% (50)

<.001

Any public insurance

40% (193)

64% (70)

<.001

Income < $30K

27% (131)

61% (65)

<.001

Income ≥ $30K to $75K

37% (181)

30% (32)

Income > $75K

36% (174)

9% (10)

Maternal education less than college

65% (316)

79% (85)

0.004

Food assistance in past year

15% (73)

35% (38)

<.001

Private MD in past year

75% (368)

61% (66)

0.003

GFR (ml/min|1.73m2)

49 [36, 60]

56 [42, 67]

0.006

Urine protein:creatinine, mg/mg of creatinine

0.28 [0.11, 0.78]

0.32 [0.13, 0.94]

0.223

Normal proteinuria (< 0.2 mg/mg of Cr)

42% (197)

36% (38)

0.220

Elevated proteinuria (0.2 to 2 mg/mg of Cr)

51% (239)

52% (55)

Nephrotic proteinuria (>2 mg/mg of Cr)

8% (36)

12% (13)

Height percentile

24.8 [7.2, 54.8]

33.8 [9.0, 61]

0.110

Weight percentile

42.4 [15.9, 75.3]

55.1 [19.5, 83.4]

0.090

BMI percentile

62.3 [33.8, 87.2]

64.0 [33.0, 89.4]

0.432

SBP percentile

64.3 [36.8, 84.8]

67.7 [44.4, 90.5]

0.047

DBP percentile

68.4 [45.1, 87.0]

79.9 [59.1, 92.7]

<.001

Hypertension

32% (154)

41% (43)

0.113

Total study visits

2089

455

--

Total person-years

2177.5

475.4

--

Any renal replacement therapy (RRT)

21% (104)

28% (31)

--

Dialysis as first RRT

10% (47)

23% (25)

--

Transplant as first RRT

12% (57)

5% (6)

--

P-value

Socioeconomic indicators

Author Manuscript

Renal characteristics at study entry

Author Manuscript

Clinical characteristics at study entry

Longitudinal data

Author Manuscript
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Table 2

Author Manuscript

Multivariate logistic regression results from propensity score model estimating the odds of being African
American race. Bold indicates p < 0.05.
Variable

Odds ratio

95% confidence interval

Male

2.33

(1.40, 3.88)

Income < $30K

2.31

(1.33, 4.03)

1

NA

Income > $75K

0.37

(0.17, 0.80)

Abnormal birth history

2.12

(1.32, 3.42)

Food assistance in past year

1.43

(0.81, 2.54)

Any public insurance

1.27

(0.75, 2.15)

Maternal education less than college

0.95

(0.53, 1.72)

Private MD in past year

0.71

(0.44, 1.14)

Income ≥ $30K to $75K

Author Manuscript
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Author Manuscript
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Table 3

Author Manuscript

Baseline demographic, socioeconomic and clinical characteristics based on weighted pseudopopulation from
the propensity score logistic model. P-values are based on weighted t-tests for continuous variables and the
Chi-square test for categorical variables.
Variable

Non-African American
N= 493

African American
N= 110

Age at study entry

10.0 [6.5, 13.4]

10.5 [6.7, 14.6]

0.251

Male

66% (325.3)

71% (74.4)

0.328

Hispanic ethnicity

17% (82.4)

10% (10.7)

0.090

Congenital CKD

72% (355.7)

70% (73.3)

0.630

Birth weight (g)

3147 [2693, 3572]

3090 [2807, 3487]

0.704

Abnormal birth history

32% (151.7)

30% (29.2)

0.599

Any private insurance

69% (326.7)

62% (65)

0.200

Any public insurance

45% (213.4)

48% (50.5)

0.519

Income < $30K

33% (161.4)

33% (34.3)

0.826

Income ≥ $30K to $75K

36% (174.9)

39% (39.6)

Income > $75K

31% (150.4)

28% (28.9)

Maternal education less than college

68% (329.5)

71% (73.5)

0.562

Food assistance in past year

19% (92)

21% (21.8)

0.629

Private MD in past year

73% (356.4)

74% (77.6)

0.744

GFR (ml/min|1.73m2)

49 [36, 60]

58 [43, 68]

<.001

Urine protein:creatinine, mg/mg of creatinine

0.3 [0.11, 0.78]

0.21 [0.09, 0.71]

0.134

Normal proteinuria (< 0.2 mg/mg of Cr)

41% (194.2)

48% (49.4)

0.245

Elevated proteinuria (0.2 to 2 mg/mg of Cr)

51% (241.8)

42% (42.9)

Nephrotic proteinuria (>2 mg/mg of Cr)

8% (36)

9% (9.6)

Height percentile

23.7 [6.6, 53.2]

29.9 [8.4, 56.7]

0.311

Weight percentile

41.6 [15.0, 74.7]

51.5 [20.4, 80.8]

0.100

BMI percentile

63.1 [33.7, 88.4]

62.2 [32.6, 89.7]

0.611

SBP percentile

64.7 [37.4, 84.8]

66.2 [46.6, 90.5]

0.014

DBP percentile

68.7 [45.1, 87.4]

79.9 [57.1, 91.1]

<.001

Hypertension

33% (156.1)

40% (40.7)

0.167

P-value

Socioeconomic indicators

Author Manuscript

Renal characteristics at study entry

Author Manuscript

Clinical characteristics

Author Manuscript
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Table 4

Author Manuscript

GFR at study entry (ml/min|1.73m2) and percent change per year, by race, based on mixed effects (random
intercepts and slopes) regression models.
Unadjusted

GFR at study entry (95%CI)
P-value
Change per year (95% CI)
P-value

Adjusted for SES

Non-African American

African American

Non-African American

African American

47.9 (46.4, 49.3)

53.3 (50.0, 56.8)

47.8 (46.3, 49.2)

55.0 (50.9, 59.4)

Reference

0.003

Reference

0.001

−4.3% (−5.1%, −3.6%)

−6.2% (−7.8%, −4.6%)

−4.4% (−5.1%, −3.6%)

−6.2% (−8.2%, −4.1%)

Reference

0.040

Reference

0.098
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